ACAD
NASDAQ · Biotechnology
Acadia Pharmaceuticals Inc
$21.24
-0.23 (-1.07%)
Performance
1D
—
1W
+3.16%
1M
+8.09%
3M
-27.73%
6M
-2.57%
1Y
-1.89%
YTD
-19.21%
Open$21.98
Previous Close$21.47
Day High$22.63
Day Low$21.14
52W High$30.96
52W Low$18.39
Volume—
Avg Volume1.44M
Market Cap3.58B
P/E Ratio9.40
EPS$2.21
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$23.20
Below
SMA 200
$23.60
Below
RSI (14)
67
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
26 analysts
Price Target
-15.7% upside
Current
$21.24
$21.24
Target
$17.90
$17.90
$12.70
$17.90 avg
$23.84
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.11B | 975.21M | 1.03B |
| Net Income | 405.08M | 320.28M | 167.73M |
| Profit Margin | 36.5% | 34.7% | 16.3% |
| EBITDA | 109.49M | 91.38M | 233.13M |
| Free Cash Flow | — | — | 189.95M |
| Rev Growth | +13.8% | +13.8% | +10.0% |
| Debt/Equity | — | — | 0.91 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |